Source link : https://www.newshealth.biz/health-news/scripts-for-glp-1-sglt2-drugs-on-the-rise-in-type-1-diabetes-patients/
GLP-1 receptor agonist or SGLT2 inhibitor prescribing became more common for people with type 1 diabetes in recent years, a nationwide cross-sectional analysis found. From 2010 to 2023, the percentage of type 1 diabetes patients prescribed an agent from one of these two classes increased from 0.7% to 8.3%, with the bulk of the increase […]
Author : News Health
Publish date : 2024-10-23 21:33:33
Copyright for syndicated content belongs to the linked Source.